Cephalon Beats Challenge To Narcolepsy Drug Patent
A Delaware federal judge on Saturday handed a win to Cephalon Inc. in its patent infringement suit aiming to block the sale of generic versions of the narcolepsy drug Nuvigil, rejecting...To view the full article, register now.
Already a subscriber? Click here to view full article